1932

Abstract

Abstract

The glycoprotein (gp) 120 subunit is an important part of the envelope spikes that decorate the surface of HIV-1 and a major target for neutralizing antibodies. However, immunization with recombinant gp120 does not elicit neutralizing antibodies against multiple HIV-1 isolates (broadly neutralizing antibodies), and gp120 failed to demonstrate vaccine efficacy in recent clinical trials. Ongoing crystallographic studies of gp120 molecules from HIV-1 and SIV increasingly reveal how conserved regions, which are the targets of broadly neutralizing antibodies, are concealed from immune recognition. Based on this structural insight and that from studies of antibody structures, a number of strategies are being pursued to design immunogens that can elicit broadly neutralizing antibodies to gp120. These include () the construction of mimics of the viral envelope spike and () the design of antigens specifically tailored to induce broadly neutralizing antibodies.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.immunol.24.021605.090557
2006-04-23
2024-06-21
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.immunol.24.021605.090557
Loading
/content/journals/10.1146/annurev.immunol.24.021605.090557
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error